KREBS BIOCHEMICALS & INDUSTRIES
Back to Balance Sheet
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹104 Cr | ₹62 Cr | ₹49 Cr | ₹78 Cr | ₹48 Cr |
What is the latest Total Current Liabilities ratio of KREBS BIOCHEMICALS & INDUSTRIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹104 Cr |
| Mar2024 | ₹62 Cr |
| Mar2023 | ₹49 Cr |
| Mar2022 | ₹78 Cr |
| Mar2021 | ₹48 Cr |
How is Total Current Liabilities of KREBS BIOCHEMICALS & INDUSTRIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹104 Cr | 67.43 | |
| Mar2024 | ₹62 Cr | 25.92 | |
| Mar2023 | ₹49 Cr | -37.10 | |
| Mar2022 | ₹78 Cr | 61.99 | |
| Mar2021 | ₹48 Cr | - | |
Compare Total Current Liabilities of peers of KREBS BIOCHEMICALS & INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KREBS BIOCHEMICALS & INDUSTRIES | ₹126.9 Cr | 7% | 1.8% | -24.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KREBS BIOCHEMICALS & INDUSTRIES | 7% |
1.8% |
-24.9% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses